Uniconazole-P; Pesticide Tolerances, 51732-51736 [E8-20548]

Agencies

• ENVIRONMENTAL PROTECTION AGENCY

[Federal Register Volume 73, Number 173 (Friday, September 5, 2008)]
[Rules and Regulations]
[Pages 51732-51736]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-20548]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[EPA-HQ-OPP-2007-1199; FRL-8376-6]


Uniconazole-P; Pesticide Tolerances

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This regulation establishes a tolerance for combined residues 
of uniconazole-P, its R-enantiomer and its Z-isomer in or on vegetable, 
fruiting, group 8. Interregional Research Project Number 4 (IR-4) 
requested this tolerance under the Federal Food, Drug, and Cosmetic Act 
(FFDCA).

DATES: This regulation is effective September 5, 2008. Objections and 
requests for hearings must be received on or before November 4, 2008, 
and must be filed in accordance with the instructions provided in 40 
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).

ADDRESSES: EPA has established a docket for this action under docket 
identification (ID) number EPA-HQ-OPP-2007-1199. To access the 
electronic docket, go to https://www.regulations.gov, select ``Advanced 
Search,'' then ``Docket Search.'' Insert the docket ID number where 
indicated and select the ``Submit'' button. Follow the instructions on 
the regulations.gov website to view the docket index or access 
available documents. All documents in the docket are listed in the 
docket index available in regulations.gov. Although listed in the 
index, some information is not publicly available, e.g., Confidential 
Business Information (CBI) or other information whose disclosure is 
restricted by statute. Certain other material, such as copyrighted 
material, is not placed on the Internet and will be publicly available 
only in hard copy form. Publicly available docket materials are 
available in the electronic docket at https://www.regulations.gov, or, 
if only available in hard copy, at the OPP Regulatory Public Docket in 
Rm. S-4400, One Potomac Yard (South Bldg.), 2777 S. Crystal Dr., 
Arlington, VA. The Docket Facility is open from 8:30 a.m. to 4 p.m., 
Monday through Friday, excluding legal holidays. The Docket Facility 
telephone number is (703) 305-5805.

FOR FURTHER INFORMATION CONTACT: Susan Stanton, Registration Division 
(7505P), Office of Pesticide Programs, Environmental Protection Agency, 
1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone 
number: (703) 305-5218; e-mail address: stanton.susan@epa.gov.

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    You may be potentially affected by this action if you are an 
agricultural producer, food manufacturer, or pesticide manufacturer. 
Potentially affected entities may include, but are not limited to those 
engaged in the following activities:
     Crop production (NAICS code 111).
     Animal production (NAICS code 112).
     Food manufacturing (NAICS code 311).
     Pesticide manufacturing (NAICS code 32532).
    This listing is not intended to be exhaustive, but rather to 
provide a guide for readers regarding entities likely to be affected by 
this action. Other types of entities not listed in this unit could also 
be affected. The North American Industrial Classification System 
(NAICS) codes have been provided to assist you and others in 
determining whether this action might apply to certain entities. If you 
have any questions regarding the applicability of this action to a 
particular entity, consult the person listed under FOR FURTHER 
INFORMATION CONTACT.

B. How Can I Access Electronic Copies of this Document?

    In addition to accessing an electronic copy of this Federal 
Register document through the electronic docket at https://
www.regulations.gov, you may access this Federal Register document 
electronically through the EPA Internet under the ``Federal Register'' 
listings at https://www.epa.gov/fedrgstr. You may also access a 
frequently updated electronic version of EPA's tolerance regulations at 
40 CFR part 180 through the Government Printing Office's pilot e-CFR 
site at https://www.gpoaccess.gov/ecfr.

C. Can I File an Objection or Hearing Request?

    Under section 408(g) of FFDCA, any person may file an objection to 
any aspect of this regulation and may also request a hearing on those 
objections. You must file your objection or request a hearing on this 
regulation in accordance with the instructions provided in 40 CFR part 
178. To ensure proper receipt by EPA, you must identify docket ID 
number EPA-HQ-OPP-2007-1199 in the subject line on the first page of 
your submission. All requests must be in writing, and must be mailed or 
delivered to the Hearing Clerk as required by 40 CFR part 178 on or 
before November 4, 2008.
    In addition to filing an objection or hearing request with the 
Hearing Clerk as described in 40 CFR part 178, please submit a copy of 
the filing that does not contain any CBI for inclusion in the public 
docket that is described in ADDRESSES. Information not marked 
confidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA 
without prior notice. Submit this copy, identified by docket ID number 
EPA-HQ-OPP-2007-1199, by one of the following methods:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the on-line instructions for submitting comments.
     Mail: Office of Pesticide Programs (OPP) Regulatory Public 
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania 
Ave., NW., Washington, DC 20460-0001.
     Delivery: OPP Regulatory Public Docket (7502P), 
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South 
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only 
accepted during the Docket's normal hours of operation (8:30 a.m. to 4 
p.m., Monday through Friday, excluding legal holidays). Special 
arrangements should be made for deliveries of boxed information. The 
Docket Facility telephone number is (703) 305-5805.

II. Petition for Tolerance

    In the Federal Register of February 6, 2008 (73 FR 6964) (FRL-8350-
9), EPA issued a notice pursuant to section 408(d)(3) of FFDCA, 21 
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP 
7E7268) by Interregional Research Project Number 4 (IR-4), 500 College 
Road East, Suite 201 W, Princeton, NJ 08540. The petition requested 
that 40 CFR part 180 be amended by adding a section for the fungicide 
uniconazole-P and

[[Page 51733]]

establishing a tolerance therein for residues of uniconazole-P per se 
in or on vegetable, fruiting, group 8 at 0.01 parts per million (ppm). 
That notice referenced a summary of the petition prepared by Valent USA 
Corporation, the registrant, which is available to the public in the 
docket, https://www.regulations.gov. There were no comments received in 
response to the notice of filing.
    Based upon review of the data supporting the petition, EPA has 
modified the tolerance expression to include uniconazole-P, its R-
enantiomer and its Z-isomer. The reason for this change is explained in 
Unit IV.C.

III. Aggregate Risk Assessment and Determination of Safety

    Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a 
tolerance (the legal limit for a pesticide chemical residue in or on a 
food) only if EPA determines that the tolerance is ``safe.'' Section 
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a 
reasonable certainty that no harm will result from aggregate exposure 
to the pesticide chemical residue, including all anticipated dietary 
exposures and all other exposures for which there is reliable 
information.'' This includes exposure through drinking water and in 
residential settings, but does not include occupational exposure. 
Section 408(b)(2)(C) of FFDCA requires EPA to give special 
consideration to exposure of infants and children to the pesticide 
chemical residue in establishing a tolerance and to ``ensure that there 
is a reasonable certainty that no harm will result to infants and 
children from aggregate exposure to the pesticide chemical residue. . . 
.''
    Consistent with section 408(b)(2)(D) of FFDCA, and the factors 
specified in section 408(b)(2)(D) of FFDCA, EPA has reviewed the 
available scientific data and other relevant information in support of 
this action. EPA has sufficient data to assess the hazards of and to 
make a determination on aggregate exposure for the petitioned-for 
tolerance for combined residues of uniconazole-P, its R-enantiomer and 
its Z-isomer on vegetable, fruiting, group 8 at 0.01 ppm. EPA's 
assessment of exposures and risks associated with establishing this 
tolerance follows.

A. Toxicological Profile

    EPA has evaluated the available toxicity data and considered its 
validity, completeness, and reliability as well as the relationship of 
the results of the studies to human risk. EPA has also considered 
available information concerning the variability of the sensitivities 
of major identifiable subgroups of consumers, including infants and 
children.
    Uniconazole-P (hereafter referred to as uniconazole) is rapidly 
absorbed after oral ingestion and extensively metabolized by the liver. 
There is no accumulation in the tissues, and the metabolites are 
rapidly excreted in the feces and urine. Uniconazole has moderate acute 
oral toxicity and low acute dermal and inhalation toxicity. It is a 
slight eye irritant but not a skin irritant or skin sensitizer. In 
mouse, rat and dog repeated-dose studies, oral ingestion of high doses 
caused an increase in the size and weight of the liver. Fat 
accumulation in the liver was also consistently observed at high doses. 
Although observed less consistently, increases in the activity of some 
enzymes indicated altered liver function as a response to uniconazole 
exposure. There was no evidence of carcinogenicity in the combined 
chronic toxicity/carcinogenicity study in the rat; however, in the 
mouse study an increase in liver neoplasms was noted. Mutagenicity 
studies were generally negative except for the in vitro mammalian 
chromosome aberration test (CHO), which was positive with metabolic 
activation. Based on the limited evidence of carcinogenicity in the 
mouse, EPA classified uniconazole as a Group C (Possible Human) 
carcinogen but concluded that quantification of cancer risk using a low 
dose extrapolation model was not appropriate. The point of Departure 
(POD) selected for deriving the chronic reference dose will adequately 
account for all chronic effects determined to result from exposure to 
uniconazole in chronic animal studies, including potential cancer 
effects. Uniconazole had no effects on reproductive performance of rats 
in the 2-generation reproduction toxicity study and no effect on fetal 
development in the rabbit developmental toxicity study. In the 
developmental toxicity study in rats, developmental toxicity (increased 
incidence of 14th ribs) was noted, but only at doses that 
were also maternally toxic. There was no evidence of neurotoxicity in 
the submitted uniconazole toxicity studies or in the open literature.
    Specific information on the studies received and the nature of the 
adverse effects caused by uniconazole, as well as the no-observed-
adverse-effect-level (NOAEL) and the lowest-observed-adverse-effect-
level (LOAEL) from the toxicity studies, can be found at https://
www.regulations.gov in the document Uniconazole-P Human Health Risk 
Assessment for Proposed Uses on Fruiting Vegetables (Except Cucurbits), 
Crop Group 8 pages 52-75 in docket ID number EPA-HQ-OPP-2007-1199.

B. Toxicological Endpoints

    For hazards that have a threshold below which there is no 
appreciable risk, a toxicological POD is identified as the basis for 
derivation of reference values for risk assessment. The POD may be 
defined as the highest dose at which no adverse effects are observed 
(the NOAEL) in the toxicology study identified as appropriate for use 
in risk assessment. However, if a NOAEL cannot be determined, the 
lowest dose at which adverse effects of concern are identified (the 
LOAEL) or a Benchmark Dose (BMD) approach is sometimes used for risk 
assessment. Uncertainty/safety factors (UFs) are used in conjunction 
with the POD to take into account uncertainties inherent in the 
extrapolation from laboratory animal data to humans and in the 
variations in sensitivity among members of the human population as well 
as other unknowns. Safety is assessed for acute and chronic dietary 
risks by comparing aggregate food and water exposure to the pesticide 
to the acute population adjusted dose (aPAD) and chronic population 
adjusted dose (cPAD). The aPAD and cPAD are calculated by dividing the 
POD by all applicable UFs. Aggregate short-term, intermediate-term, and 
chronic-term risks are evaluated by comparing food, water, and 
residential exposure to the POD to ensure that the margin of exposure 
(MOE) called for by the product of all applicable UFs is not exceeded. 
This latter value is referred to as the Level of Concern (LOC).
    For non-threshold risks, the Agency assumes that any amount of 
exposure will lead to some degree of risk. Thus, the Agency estimates 
risk in terms of the probability of an occurrence of the adverse effect 
greater than that expected in a lifetime. For more information on the 
general principles EPA uses in risk characterization and a complete 
description of the risk assessment process, see https://www.epa.gov/
pesticides/factsheets/riskassess.htm.
    A summary of the toxicological endpoints for uniconazole used for 
human risk assessment can be found at https://www.regulations.gov in the 
document Uniconazole-P Human Health Risk Assessment for Proposed Uses 
on Fruiting Vegetables (Except Cucurbits), Crop Group 8 pages 26-27 in 
docket ID number EPA-HQ-OPP-2007-1199.

C. Exposure Assessment

    1. Dietary exposure from food and feed uses. In evaluating dietary

[[Page 51734]]

exposure to uniconazole, EPA considered exposure under the petitioned-
for tolerance on fruiting vegetables, the first food use of 
uniconazole. EPA assessed dietary exposures from uniconazole in food as 
follows:
    i. Acute exposure. Quantitative acute dietary exposure and risk 
assessments are performed for a food-use pesticide, if a toxicological 
study has indicated the possibility of an effect of concern occurring 
as a result of a 1-day or single exposure. EPA identified such an 
effect relevant to the population group females, 13 years of age and 
older (increased incidence of 14th rib following in utero 
exposure to uniconazole in the rat developmental toxicity study). No 
acute effects were identified for the general population, including 
infants and children.
    In estimating acute dietary exposure, EPA used food consumption 
information from the United States Department of Agriculture (USDA) 
1994-1996 Nationwide Continuing Surveys of Food Intakes by Individuals 
(CSFII). As to residue levels in food, EPA assumed that all foods 
covered by the fruiting vegetable tolerance contain tolerance-level 
residues and that 100% of fruiting vegetables are treated with 
uniconazole.
    ii. Chronic exposure. In conducting the chronic dietary exposure 
assessment EPA used the food consumption data from the USDA 1994-1996 
and 1998 CSFII. As to residue levels in food, EPA again assumed that 
all foods covered by the fruiting vegetable tolerance contain 
tolerance-level residues and that 100% of fruiting vegetables are 
treated with uniconazole.
    iii. Cancer. Based upon statistically significant increases in 
hepatocellular neoplasms in high-dose male mice, EPA classified 
uniconazole as a Group C (Possible Human) carcinogen but concluded that 
quantification of cancer risk using a low dose extrapolation model was 
not appropriate. This determination was based on the fact that the 
tumor induced is primarily of a benign nature, occurred at the highest 
dose tested in one sex of one species only with no acceleration in the 
rate of tumor formation and did not exhibit any uncommon biological 
behavior. The POD selected for deriving the chronic reference dose 
(cRfD) will adequately account for all chronic effects determined to 
result from exposure to uniconazole in chronic animal studies, 
including potential cancer effects.
    iv. Anticipated residue and percent crop treated (PCT) information. 
EPA did not use anticipated residue and/or PCT information in the 
dietary assessment for uniconazole. Tolerance level residues and 100 
PCT were assumed for all food commodities.
    2. Dietary exposure from drinking water. The Agency used screening 
level water exposure models in the dietary exposure analysis and risk 
assessment for uniconazole in drinking water. These simulation models 
take into account data on the physical, chemical, and fate/transport 
characteristics of uniconazole. Further information regarding EPA 
drinking water models used in pesticide exposure assessment can be 
found at https://www.epa.gov/oppefed1/models/water/index.htm.
    Based on the First Index Reservoir Screening Tool (FIRST) and 
Screening Concentration in Ground Water (SCI-GROW) models, the 
estimated drinking water concentrations (EDWCs) of uniconazole for 
acute exposures are estimated to be 3.1 parts per billion (ppb) for 
surface water and 0.076 ppb for ground water; and for chronic exposures 
for non-cancer assessments are estimated to be 1.5 ppb for surface 
water and 0.076 ppb for ground water.
    Modeled estimates of drinking water concentrations were directly 
entered into the dietary exposure model. For acute dietary risk 
assessment, the water concentration value of 3.1 ppb was used to assess 
the contribution to drinking water. For chronic dietary risk 
assessment, the water concentration of value 1.5 ppb was used to assess 
the contribution to drinking water.
    3. From non-dietary exposure. The term ``residential exposure'' is 
used in this document to refer to non-occupational, non-dietary 
exposure (e.g., for lawn and garden pest control, indoor pest control, 
termiticides, and flea and tick control on pets). Uniconazole is not 
registered for any specific use patterns that would result in 
residential exposure.
    4. Cumulative effects from substances with a common mechanism of 
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when 
considering whether to establish, modify, or revoke a tolerance, the 
Agency consider ``available information'' concerning the cumulative 
effects of a particular pesticide's residues and ``other substances 
that have a common mechanism of toxicity.''
    Uniconazole is a member of the triazole-containing class of 
pesticides, sometimes referred to as conazoles. Although conazoles act 
similarly in fungi by inhibiting ergosterol biosynthesis, there is not 
necessarily a relationship between their pesticidal activity and their 
mechanism of toxicity in mammals. Structural similarities do not 
constitute a common mechanism of toxicity. Evidence is needed to 
establish that the chemicals operate by the same, or essentially the 
same, sequence of major biochemical events. In conazoles, however, a 
variable pattern of toxicological responses is found. Some are 
hepatotoxic and hepatocarcinogenic in mice. Some induce thyroid tumors 
in rats. Some induce developmental, reproductive and neurological 
effects in rodents. Furthermore, the conazoles produce a diverse range 
of biochemical events, including altered cholesterol levels, stress 
responses, and altered DNA methylation. It is not clearly understood 
whether these biochemical events are directly connected to their 
toxicological outcomes. Thus, there is currently no evidence to 
indicate that conazoles share common mechanisms of toxicity and EPA is 
not following a cumulative risk approach based on a common mechanism of 
toxicity for the conazoles. For information regarding EPA's efforts to 
determine which chemicals have a common mechanism of toxicity and to 
evaluate the cumulative effects of such chemicals, see EPA's website at 
https://www.epa.gov/pesticides/cumulative.
    Uniconazole is a triazole-derived pesticide. This class of 
compounds can form the common metabolite 1,2,4-triazole and several 
triazole conjugates (including triazole alanine, triazole acetic acid, 
triazole pyruvic acid and triazole lactic acid). To support existing 
tolerances and to establish new tolerances for triazole-derivative 
pesticides, including uniconazole, EPA conducted a human health risk 
assessment for exposure to 1,2,4-triazole, triazole alanine, and 
triazole acetic acid resulting from the use of all current and pending 
uses of any triazole-derived fungicide. Triazole pyruvic acid and 
triazole lactic acid were not included in the risk assessment due to 
their low occurrence in metabolism studies. The risk assessment is a 
highly conservative, screening-level evaluation in terms of hazards 
associated with common metabolites (e.g., use of a maximum combination 
of uncertainty factors) and potential dietary and non-dietary exposures 
(i.e., high end estimates of both dietary and non-dietary exposures). 
In addition, the Agency retained the additional 10X FQPA safety factor 
for the protection of infants and children. The assessment includes 
evaluations of risks for various subgroups, including those comprised 
of infants and children. The Agency's complete risk assessment is found 
in the propiconazole reregistration docket at https://
www.regulations.gov (Docket ID EPA-

[[Page 51735]]

HQ-OPP-2005-0497). Additional information regarding the uses proposed 
for uniconazole in this action can also be found at https://
www.regulations.gov in the documents Dietary Exposure Assessments for 
the Common Triazole Metabolites 1,2,4-Triazole, Triazolylalanine, 
Triazolylacetic Acid, and Triazolylypyruvic Acid; Updated to Include 
New Uses of Fenbuconazole, Ipconazole, Metconazole, Tebuconazole, and 
Uniconazole; and a Change in Plant-back Restriction for Tetraconazole 
and Uniconazole-P: Acute, Chronic and Cancer Aggregate Dietary (Food 
and Drinking Water) Exposure Analyses for the Section 3 Registration 
Action in docket ID number EPA-HQ-OPP-2007-1199.

D. Safety Factor for Infants and Children

    1. In general. Section 408(b)(2)(c) of FFDCA provides that EPA 
shall apply an additional tenfold (10X) margin of safety for infants 
and children in the case of threshold effects to account for prenatal 
and postnatal toxicity and the completeness of the database on toxicity 
and exposure unless EPA determines based on reliable data that a 
different margin of safety will be safe for infants and children. This 
additional margin of safety is commonly referred to as the FQPA safety 
factor (SF). In applying this provision, EPA either retains the default 
value of 10X, or uses a different additional safety factor when 
reliable data available to EPA support the choice of a different 
factor.
    2. Prenatal and postnatal sensitivity. The prenatal and postnatal 
toxicology database for uniconazole includes rat and rabbit 
developmental toxicity studies and a 2-generation reproduction toxicity 
study in rats. There was no evidence of increased qualitative or 
quantitative susceptibility of rabbit fetuses following in utero 
exposure to uniconazole and no evidence of increased susceptibility of 
offspring in the 2-generation reproduction study in rats. There was 
evidence of increased qualitatative susceptibility of fetuses in the 
rat developmental study. In this study, an increased incidence of 
14th rib in the fetuses was observed in the presence of 
minimal maternal toxicity (decreased body weight). The degree of 
concern for the qualitative susceptibility seen in the rat 
developmental study is low because:
     The additional rib was the only skeletal variation noted
     The fetal effect occurred only in the presence of maternal 
toxicity
     In the reproduction study in rats, higher doses resulted 
in minimal pup toxicity (slightly reduced body weights); and:
     The NOAEL for the fetal effect is used for assessing acute 
risk of females 13 years and older and is, therefore, protective of 
potential developmental effects.
    3. Conclusion. EPA has determined that reliable data show the 
safety of infants and children would be adequately protected if the 
FQPA SF were reduced to 1X. That decision is based on the following 
findings:
    i. The uniconazole database is adequate to assess prenatal and 
postnatal toxicity.
    ii. There is no indication that uniconazole is a neurotoxic 
chemical and there is no need for a developmental neurotoxicity study 
or additional UFs to account for neurotoxicity.
    iii. Although there is qualitative evidence of increased 
susceptibility in the prenatal developmental study in rats, EPA did not 
identify any residual uncertainties after establishing toxicity 
endpoints and traditional UFs to be used in the risk assessment of 
uniconazole. The degree of concern for prenatal and/or postnatal 
toxicity is low.
    iv. There are no residual uncertainties identified in the exposure 
databases. The dietary food exposure assessments were performed 
assuming 100 PCT and tolerance-level residues. EPA made conservative 
(protective) assumptions in the ground and surface water modeling used 
to assess exposure to uniconazole in drinking water. Residential 
exposure to uniconazole is not expected. These assessments will not 
underestimate the exposure and risks posed by uniconazole.

E. Aggregate Risks and Determination of Safety

    EPA determines whether acute and chronic pesticide exposures are 
safe by comparing aggregate exposure estimates to the aPAD and cPAD. 
The aPAD and cPAD represent the highest safe exposures, taking into 
account all appropriate SFs. EPA calculates the aPAD and cPAD by 
dividing the POD by all applicable UFs. For linear cancer risks, EPA 
calculates the probability of additional cancer cases given the 
estimated aggregate exposure. Short-term, intermediate-term, and 
chronic-term risks are evaluated by comparing the estimated aggregate 
food, water, and residential exposure to the POD to ensure that the MOE 
called for by the product of all applicable UFs is not exceeded.
    1. Acute risk. An acute aggregate risk assessment takes into 
account exposure estimates from acute dietary consumption of food and 
drinking water. Using the exposure assumptions discussed in this unit 
for acute exposure, the acute dietary exposure from food and water to 
uniconazole will occupy <1% of the aPAD for females 13 to 49 years old, 
the only population group for which an acute endpoint of concern was 
identified.
    2. Chronic risk. Using the exposure assumptions described in this 
unit for chronic exposure, EPA has concluded that chronic exposure to 
uniconazole from food and water will utilize <1% of the cPAD for the 
general population and all population subgroups, including infants and 
children. There are no residential uses for uniconazole.
    3. Short-term and intermediate-term risk. Short-term and 
intermediate-term aggregate exposure takes into account short-term and 
intermediate-term residential exposure plus chronic exposure to food 
and water (considered to be a background exposure level). Uniconazole 
is not registered for any use patterns that would result in residential 
exposure. Therefore, the short- and intermediate-term aggregate risk is 
the sum of the risk from exposure to uniconazole through food and water 
and will not be greater than the chronic aggregate risk.
    4. Aggregate cancer risk for U.S. population. The Agency has 
determined that the chronic risk assessment based on the established 
cPAD is protective of potential cancer effects. Based on the results of 
the chronic risk assessment discussed above in Unit E.2, EPA concludes 
that uniconazole is not expected to pose a cancer risk.
    5. Determination of safety. Based on these risk assessments, EPA 
concludes that there is a reasonable certainty that no harm will result 
to the general population, or to infants and children from aggregate 
exposure to uniconazole residues.

IV. Other Considerations

A. Analytical Enforcement Methodology

    Adequate enforcement methodology (Gas Chromatography/Nitrogen 
Phosphorus Detector (GC/NPD); Valent Method RM-25-1b) is available to 
enforce the tolerance expression. The method may be requested from: 
Chief, Analytical Chemistry Branch, Environmental Science Center, 701 
Mapes Rd., Ft. Meade, MD 20755-5350; telephone number: (410) 305-2905; 
e-mail address: residuemethods@epa.gov.

B. International Residue Limits

    No Codex, Canadian, or Mexican MRLs have been established for 
uniconazole.

[[Page 51736]]

C. Revisions to Petitioned-For Tolerance

    The petitioner proposed a tolerance for residues of uniconazole-P 
per se in or on vegetable, fruiting, group 8. However, based on the 
results of plant metabolism studies, EPA has determined that the 
residues of concern to be included in the tolerance expression for 
fruiting vegetables are uniconazole-P, its R-enantiomer and its Z-
isomer. Therefore, EPA has modified the tolerance expression to include 
all three compounds.

V. Conclusion

    Therefore, the tolerance is established for combined residues of 
uniconazole-P, (E)-(S)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-
triazol-1-yl)pent-1-en-3-ol, its R-enantiomer and its Z-isomer in or on 
vegetable, fruiting, group 8 at 0.01 ppm.

VI. Statutory and Executive Order Reviews

    This final rule establishes tolerances under section 408(d) of 
FFDCA in response to a petition submitted to the Agency. The Office of 
Management and Budget (OMB) has exempted these types of actions from 
review under Executive Order 12866, entitled Regulatory Planning and 
Review (58 FR 51735, October 4, 1993). Because this final rule has been 
exempted from review under Executive Order 12866, this final rule is 
not subject to Executive Order 13211, Actions Concerning Regulations 
That Significantly Affect Energy Supply, Distribution, or Use (66 FR 
28355, May 22, 2001) or Executive Order 13045, entitled Protection of 
Children from Environmental Health Risks and Safety Risks (62 FR 19885, 
April 23, 1997). This final rule does not contain any information 
collections subject to OMB approval under the Paperwork Reduction Act 
(PRA), 44 U.S.C. 3501 et seq., nor does it require any special 
considerations under Executive Order 12898, entitled Federal Actions to 
Address Environmental Justice in Minority Populations and Low-Income 
Populations (59 FR 7629, February 16, 1994).
    Since tolerances and exemptions that are established on the basis 
of a petition under section 408(d) of FFDCA, such as the tolerance in 
this final rule, do not require the issuance of a proposed rule, the 
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et 
seq.) do not apply.
    This final rule directly regulates growers, food processors, food 
handlers, and food retailers, not States or tribes, nor does this 
action alter the relationships or distribution of power and 
responsibilities established by Congress in the preemption provisions 
of section 408(n)(4) of FFDCA. As such, the Agency has determined that 
this action will not have a substantial direct effect on States or 
tribal governments, on the relationship between the national government 
and the States or tribal governments, or on the distribution of power 
and responsibilities among the various levels of government or between 
the Federal Government and Indian tribes. Thus, the Agency has 
determined that Executive Order 13132, entitled Federalism (64 FR 
43255, August 10, 1999) and Executive Order 13175, entitled 
Consultation and Coordination with Indian Tribal Governments (65 FR 
67249, November 9, 2000) do not apply to this final rule. In addition, 
this final rule does not impose any enforceable duty or contain any 
unfunded mandate as described under Title II of the Unfunded Mandates 
Reform Act of 1995 (UMRA) (Public Law 104-4).
    This action does not involve any technical standards that would 
require Agency consideration of voluntary consensus standards pursuant 
to section 12(d) of the National Technology Transfer and Advancement 
Act of 1995 (NTTAA), Public Law 104-113, section 12(d) (15 U.S.C. 272 
note).

VII. Congressional Review Act

    The Congressional Review Act, 5 U.S.C. 801 et seq., generally 
provides that before a rule may take effect, the agency promulgating 
the rule must submit a rule report to each House of the Congress and to 
the Comptroller General of the United States. EPA will submit a report 
containing this rule and other required information to the U.S. Senate, 
the U.S. House of Representatives, and the Comptroller General of the 
United States prior to publication of this final rule in the Federal 
Register. This final rule is not a ``major rule'' as defined by 5 
U.S.C. 804(2).

List of Subjects in 40 CFR Part 180

    Environmental protection, Administrative practice and procedure, 
Agricultural commodities, Pesticides and pests, Reporting and 
recordkeeping requirements.

    Dated: August 26, 2008.
Debra Edwards,
Director, Office of Pesticide Programs.

0
Therefore, 40 CFR chapter I is amended as follows:

PART 180--[AMENDED]

0
1. The authority citation for part 180 continues to read as follows:

    Authority: 21 U.S.C. 321(q), 346a and 371.

0
2. Section 180.643 is added to read as follows:


Sec.  180.643  Uniconazole; tolerances for residues.

    (a) General. Tolerances are established for residues of the 
fungicide/plant growth regulator uniconazole-P, (E)-(S)-1-(4-
chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol, its 
R-enantiomer and its Z-isomer in or on the following raw agricultural 
commodities:

------------------------------------------------------------------------
                                                              Parts per
                         Commodity                             million
------------------------------------------------------------------------
Vegetable, fruiting, group 8...............................         0.01
------------------------------------------------------------------------

    (b) Section 18 emergency exemptions. [Reserved]
    (c) Tolerances with regional registrations. [Reserved]
    (d) Indirect or inadvertant residues. [Reserved]
[FR Doc. E8-20548 Filed 9-4-08; 8:45 am]
BILLING CODE 6560-50-S